High frequencies of simultaneous FLT3-ITD, WT1 and KIT mutations in hematological malignancies with NUP98-fusion genes

Leukemia

Volumn 24, Issue 11, 2010, Pages 1975-1977

  Taketani, T ^a,b   Taki, T ^c   Nakamura, T ^d   Kobayashi, Y ^e   Ito, E ^f   Fukuda, S ^b   Yamaguchi, S ^b   Hayashi, Y ^g  

^a SHIMANE UNIVERSITY HOSPITAL   (Japan)

^b SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

^c KYOTO PREFECTURAL UNIVERSITY   (Japan)

^d CANCER INSTITUTE   (Japan)

^e NATIONAL CANCER CENTER HOSPITAL   (Japan)

^f HIROSAKI UNIVERSITY   (Japan)

^g Gumna Children S Medical Center   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FLT3 LIGAND; HOMEODOMAIN PROTEIN; NUCLEOPHOSMIN; NUCLEOPORIN; NUCLEOPORIN 98; PROTEIN A 11; PROTEIN A 13; PROTEIN C 11; PROTEIN C 13; PROTEIN D 11; PROTEIN D 13; PROTEIN HOXA 9; PROTEIN HOXD 13; PROTEIN PMX 1; TRANSCRIPTION FACTOR RUNX1; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; WT1 PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; APOPTOSIS; CELL CYCLE; CELL PROLIFERATION; CHROMOSOME TRANSLOCATION; DNA BINDING; GENE EXPRESSION; GENE FREQUENCY; GENE FUSION; GENE MUTATION; HEMATOLOGIC MALIGNANCY; HUMAN; IN SITU HYBRIDIZATION; LETTER; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

EID: 78149467263     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2010.207     Document Type: Letter

References (8)

1. Renneville A, Roumier C, Biggio V, Nibourel O, Boissel N, Fenaux P et al. Cooperating gene mutations in acute myeloid leukemia: a review of the literature. Leukemia 2008; 22: 915-931.
2. Moore MA, Chung KY, Plasilova M, Schuringa JJ, Shieh JH, Zhou P et al. NUP98 dysregulation in myeloid leukemogenesis. Ann N Y Acad Sci 2007; 1106: 114-142.
3. Ageberg M, Drott K, Olofsson T, Gullberg U, Lindmark A. Identification of a novel and myeloid specific role of the leukemia-associated fusion protein DEK-NUP214 leading to increased protein synthesis. Genes Chromosomes Cancer 2008; 47: 276-287.
4. Schlenk RF, Döhner K, Krauter J, Fröhling S, Corbacioglu A, Bullinger L et al. Mutations and treatment outcome in cytogeneti-cally normal acute myeloid leukemia. N Engl J Med 2008; 358: 1909-1918.
5. Chou WC, Chen CY, Hou HA, Lin LI, Tang JL, Yao M et al. Acute myeloid leukemia bearing t(7;11)(p15;p15) is a distinct cytogenetic entity with poor outcome and a distinct mutation profile: comparative analysis of 493 adult patients. Leukemia 2009; 23: 1303-1310.
6. Slape C, Liu LY, Beachy S, Aplan PD. Leukemic transformation in mice expressing a NUP98-HOXD13 transgene is accompanied by spontaneous mutations in Nras, Kras, and Cbl. Blood 2008; 112: 2017-2019.
7. Virappane P, Gale R, Hills R, Kakkas I, Summers K, Stevens J et al. Mutation of the wilms' tumor 1 gene is a poor prognostic factor associated with chemotherapy resistance in normal karyotype acute myeloid leukemia: The United Kingdom Medical Research Council Adult Leukaemia Working Party. J Clin Oncol 2008; 26: 5429-5435.
8. Ariyaratana S, Loeb DM. The role of the Wilms tumour gene (WT1) in normal and malignant haematopoiesis. Expert Rev Mol Med 2007; 9: 1-17.